Concise clinical guidance: evaluation and management of cardiogenic shock
Cardiogenic shock is a complex, multifactorial syndrome with up to 50 percent short-term mortality. While AMI is a well-known cause, non-AMI etiologies – especially heart failure – can be more subtle and harder to detect. Patients may present with mild hypotension or fatigue yet show early signs of hypoperfusion such as rising lactate, worsening renal function or cool extremities. Without clear signs of hemodynamic instability or invasive monitoring, escalation of therapy and other clinical management decisions can be challenging.
To address this clinical ambiguity, the American College of Cardiology (ACC) convened the Heart House Roundtable on Evaluation and Management of Cardiogenic Shock in March 2024. Chaired by Shashank S. Sinha, MD, MSc, FACC, FAHA, FHFSA, Director of Inova’s Cardiogenic Shock Program, the roundtable produced the ACC’s first concise clinical guidance, recently published in JACC. It offers a practical framework for early recognition and management including one-hour and 24-hour roadmaps for cardiogenic shock.
“At Inova, we encourage providers to call early and often,” Dr. Sinha said. “Our multidisciplinary team can rapidly assess whether the patient is in cardiogenic shock, the severity, etiology and treatment needs – within the ‘golden hour’ of acute shock. This may include advanced temporary mechanical circulatory support to help restore perfusion to vital organs.”
Another tool providers should use, developed by the Society for Cardiovascular Angiography and Interventions, is the SCAI staging system (A–E), which reflects the progressive nature of cardiogenic shock. Patients may deteriorate from stage B (hypotension without hypoperfusion) to stage C or D within hours, often unbeknownst to providers despite their best efforts. Early recognition and intervention are key.
“Our goal is to help providers recognize patients at earlier stages of cardiogenic shock so we can offer potential therapeutic interventions earlier in the disease course,” Dr. Sinha said, “thereby improving the patient’s chances of survival.”
Inova serves as a regional referral center for more than 40 hospitals across Washington, DC, Maryland, Virginia and West Virginia. Its shock team includes specialists in heart failure, interventional cardiology, ECMO, cardiothoracic surgery and critical care. Upon activation, the team reviews vitals, labs, imaging and therapies, then provides immediate recommendations and coordinates transfer if needed.
Dr. Sinha emphasized the importance of serial reassessment: “We stay engaged throughout the process and reactivate the shock team at six, 12 and 24 hours to evaluate trajectory and adjust treatment. Timely intervention improves survival – we’re here to collaborate. It’s never too early to call.”